The cereblon-AMPK (AMP-activated protein kinase) axis in chondrocytes regulates the pathogenesis of osteoarthritis
Osteoarthritis and Cartilage · 2024
DOI: 10.1016/j.joca.2024.08.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2024. Verfasst von Yeon Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Creative Research Initiatives Center for Osteoarthritis Pathogenesis, School of Life Sciences, Gwangju Institute of Science and Technology, …. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Chondrocytes, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
OBJECTIVE: AMP-activated protein kinase (AMPK) dysregulation is implicated in osteoarthritis (OA), but the mechanisms underlying this dysregulation remain unclear. We investigated the role of cereblon, a substrate-recognition protein within the E3-ligase ubiquitin complex, in AMPK dysregulation and OA pathogenesis. METHODS: Cereblon expression was examined in human (n = 5) and mouse (n = 10) OA cartilage. The role of cereblon was investigated through its adenoviral overexpression (n = 10) or knockout (KO, n = 15) in the destabilization of the medial meniscus (DMM)-operated mice. The therapeutic potentials of the chemical cereblon degrader, TD-165, and the AMPK activator, metformin, were assessed through intra-articular (IA) injection to mice (n = 15). RESULTS: Immunostaining revealed that cereblon is upregulated in human and mouse OA cartilage. In DMM model mice, cartilage destruction was exacerbated by overexpression of cereblon in mouse joint tissues (OARSI grade; 1.11 [95% CI: 0.50 to 2.75]), but inhibited in global (-2.50 [95% CI: -3.00 to -1.17]) and chondrocyte-specific (-2.17 [95% CI: -3.14 to -1.06]) cereblon KO mice. The inhibitory effects were more pronounced in mice fed a high-fat diet compared to a regular diet. The degradation of cereblon through IA injection of TD-165 inhibited OA cartilage destruction (-2.47 [95% CI: -3.22 to -1.56]). Mechanistically, cereblon exerts its catabolic effects by negatively modulating AMPK activity within chondrocytes. Consistently, activation of AMPK by IA injection of metformin inhibited posttraumatic OA cartilage destruction (-1.20 ([95% CI: -1.89 to -0.45]). CONCLUSIONS: The cereblon-AMPK axis acts as a catabolic regulator of OA pathogenesis and seems to be a promising therapeutic target in animal models of OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Creative Research Initiatives Center for Osteoarthritis Pathogenesis, School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
- National Creative Research Initiatives Center for Osteoarthritis Pathogenesis, School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. Electronic address: jschun@gist.ac.k…
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, Y., Kim, H. E., Kwak, J. S., Park, C. S., & Chun, J. S. (2024). The cereblon-AMPK (AMP-activated protein kinase) axis in chondrocytes regulates the pathogenesis of osteoarthritis. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2024.08.009
Vancouver
Lee Y, Kim HE, Kwak JS, Park CS, Chun JS. The cereblon-AMPK (AMP-activated protein kinase) axis in chondrocytes regulates the pathogenesis of osteoarthritis. Osteoarthritis and Cartilage. 2024. doi:10.1016/j.joca.2024.08.009
BibTeX
@article{Lee2024,
author = {Lee, Yeon and Kim, Hyo-Eun and Kwak, Ji-Sun and Park, Chul-Seung and Chun, Jang-Soo},
title = {The cereblon-AMPK (AMP-activated protein kinase) axis in chondrocytes regulates the pathogenesis of osteoarthritis},
journal = {Osteoarthritis and Cartilage},
year = {2024},
doi = {10.1016/j.joca.2024.08.009}
}
EUVIMED